secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK:        0001439222
Form:       8-K
Filed at:   2022-05-26T23:59:59+00:00
Accession:  0001193125-22-160979
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Agios CSO Bruce Car resigns, signs consulting agreement through March 2023
--------------------------------------------------------------------------

- Dr. Bruce Car steps down as chief scientific officer effective August 1, 2022.
- Consulting agreement runs from August 1, 2022 to March 31, 2023, extendable with consent.
- Services limited to transition and research science support, not exceeding 10 hours per week.
- Outstanding equity awards will continue to vest during the consulting term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522160979/0001193125-22-160979-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522160979/d324175d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-160979

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer